WHO ICTRP trial
Clinical Trial to evaluate the effectivity and efficiency of preemptive…
EUCTR2019-000376-41-ES · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2019-000376-41-ES |
|---|---|
| Public title | Clinical Trial to evaluate the effectivity and efficiency of preemptive genotyping before treatment with voriconazole |
| Scientific title | Randomized and multicenter clinical trial to evaluate the effectiveness and efficiency of a voriconazole preemptive genotyping strategy in patients with risk of aspergillosis. |
| Primary sponsor | Fundación de Investigación del Hospital Universitario La Paz (FIBHULP) |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | Spain |
| Conditions | Invasive fungal disease in the hematologic patient. MedDRA version: 20.0 Level: HLGT Classification code 10017528 Term: Fungal infectious disorders System Organ Class: 10021881 - Infections and infestations MedDRA version: 20.0 Level: HLT… |
| Interventions | Trade Name: Voriconazol Pharmaceutical Form: Powder for solution for injection/infusion INN or Proposed INN: VORICONAZOLE CAS Number: 137234-62-9 |
| Registration date | Dec 4, 2019 |
| Target size | 146 |
| Secondary IDs | VORIGENIPHARM |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: